Zurich Cantonal Bank
CNTA

Zurich Cantonal Bank’s Centessa Pharmaceuticals CNTA Stock Holding History

Zurich Cantonal Bank’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-438
Closed -$11K – 2782
2025
Q4 		$11K Buy
+438
New +$11.1K ﹤0.01% 2481

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Zurich Cantonal Bank's CNTA Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Centessa Pharmaceuticals (CNTA) in Q1 2026: 1 share worth $40. The stake represents ﹤0.01% of the portfolio and ranks #2531 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in CNTA as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in CNTA in Q1 2024 and has held it in 8 quarters since. The position peaked at $35.2K in Q3 2024. 161 funds tracked by Wall St. Rank hold CNTA as of Q1 2026.

  • Zurich Cantonal Bank held 1 share of Centessa Pharmaceuticals worth $40 as of Q1 2026.
  • Centessa Pharmaceuticals was a new Zurich Cantonal Bank position in Q1 2026.
  • Centessa Pharmaceuticals made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #2531 holding.
  • Zurich Cantonal Bank first reported a position in Centessa Pharmaceuticals in Q1 2024 and has held it in 8 quarters since.
  • Zurich Cantonal Bank's Centessa Pharmaceuticals position peaked at $35.2K in Q3 2024.
  • 161 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.